National Bank of Canada’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18M | Sell |
143,212
-58,321
| -29% | -$7.32M | 0.02% | 483 |
|
2025
Q1 | $27.6M | Buy |
201,533
+23,644
| +13% | +$3.24M | 0.03% | 367 |
|
2024
Q4 | $27.2M | Sell |
177,889
-13,576
| -7% | -$2.08M | 0.03% | 372 |
|
2024
Q3 | $37.1M | Buy |
191,465
+137,161
| +253% | +$26.6M | 0.04% | 301 |
|
2024
Q2 | $12.6M | Sell |
54,304
-18,520
| -25% | -$4.29M | 0.02% | 436 |
|
2024
Q1 | $16.1M | Sell |
72,824
-128,451
| -64% | -$28.5M | 0.02% | 397 |
|
2023
Q4 | $53.9M | Buy |
201,275
+84,284
| +72% | +$22.6M | 0.09% | 183 |
|
2023
Q3 | $29.6M | Buy |
116,991
+68,282
| +140% | +$17.3M | 0.05% | 268 |
|
2023
Q2 | $13.9M | Buy |
48,709
+34,971
| +255% | +$9.98M | 0.03% | 397 |
|
2023
Q1 | $3.82M | Sell |
13,738
-9,333
| -40% | -$2.59M | 0.01% | 590 |
|
2022
Q4 | $6.39M | Sell |
23,071
-3,430
| -13% | -$950K | 0.02% | 490 |
|
2022
Q3 | $7.01M | Sell |
26,501
-1,243
| -4% | -$329K | 0.04% | 387 |
|
2022
Q2 | $5.84M | Sell |
27,744
-82
| -0.3% | -$17.3K | 0.03% | 431 |
|
2022
Q1 | $6.11M | Buy |
27,826
+23,844
| +599% | +$5.24M | 0.02% | 445 |
|
2021
Q4 | $960K | Buy |
+3,982
| New | +$960K | ﹤0.01% | 923 |
|